Nutritional interventions in depression and perinatal depression

Yale Journal of Biology and Medicine

Volumn 86, Issue 2, 2013, Pages 127-137

  Rechenberg, Kaitlyn ^a,b   Humphries, Debbie ^a  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF NURSING   (United States)

Author keywords

Depression; Nutrition; Perinatal depression

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; ANTIDEPRESSANT AGENT; CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; FLUOXETINE; FOLIC ACID; HOMOCYSTEINE; ICOSAPENTAENOIC ACID; IMIPRAMINE; NORTRIPTYLINE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PLACEBO; POLYUNSATURATED FATTY ACID; PYRIDOXINE; S ADENOSYLMETHIONINE; SERTRALINE; TRAZODONE;

ADD ON THERAPY; AMINO ACID METABOLISM; ARTICLE; BRAIN FUNCTION; DEPRESSION; DRUG EFFECT; DRUG TOLERABILITY; FOLIC ACID DEFICIENCY; HUMAN; MAJOR DEPRESSION; MATERNAL NUTRITION; MONOAMINERGIC SYSTEM; MOOD CHANGE; NEUROTRANSMITTER RELEASE; NONHUMAN; NUTRIENT MANAGEMENT; NUTRITIONAL HEALTH; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PATHOPHYSIOLOGY; PERINATAL DEPRESSION; PREGNANCY OUTCOME; TREATMENT DURATION;

DEPRESSION; NUTRITION; PERINATAL DEPRESSION;

BRAIN; DEPRESSION; DEPRESSION, POSTPARTUM; FATTY ACIDS, UNSATURATED; FEMALE; HOMOCYSTEINE; HUMANS; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; PREGNANCY;

EID: 84879064496     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. The World Health Organization: Depression: A Global Public Health Concern [Internet]. [cited 2012 Dec 28] Available from: http://www.who.int/mental_health/management/depression/who_paper_depression_wfmh_2012.pdf.
2. Goldman LS, Nielsen NH, Champion HC. Awareness, diagnosis, and treatment of depression. J Gen Intern Med. 1999;14(9):569-80.
3. The World Health Organization: Gender and Women's Mental Health [Internet]. [cited 2012 Dec 28] Available from: http://www.who.int/mental_health/prevention/genderwomen/en/.
4. Bennett HA, Einarson A, Taddio A, Koren G, Einarson T. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol. 2004;103(4):698-709.
5. The World Health Organization: WHO Program for Depression in Public Health [Internet].[ cited 2012 Dec 28] Available from: http://www.who.int/mental_health/management/depression/depressioninph/en/.
6. Leung BM, Kaplan BJ. Perinatal depression: prevalence, risks, and the nutrition link-a review of the literature. J Am Diet Assoc. 2009;109(9);1566-75.
7. Bowen A, Muhajarine N. Antenatal Depression: Nurses who understand the prevalence, signs and symptoms, can risk factors associated with antenatal depression (AD) can play a valuable role in identifying AD and preventing the sequelae in pregnant women and their families. Can Nurse. 2006;102(9):26-30.
8. Zonana JE, Gorman JM. The neurobiology of postpartum depression. CNS Spectr. 2005;10(10):792-9,805.
9. Bowen A, Muhajarine N. Prevalence of antenatal depression in women enrolled in an outreach program in Canada. J Obstet Gynecol Neonatal Nurs. 2006;35(4):491-8.
10. Stewart R. Maternal depression and infant growth - a review of recent evidence. Matern Child Nutr. 2007;3(2):94-107.
11. Stein A, Malmberg L, Sylva K, Barnes J, Leach P. The influence of maternal depression, caregiving, and socioeconomic status in the post-natal year on children's language development. Child Care Health Dev. 2008;34(5):603-12.
12. Pawlby SJ, Sharp DJ, Hay DF, O'Keane V. Antenatal depression predicts depression in adolescent offspring: Prospective longitudinal community-based study. J Affect Disord. 2009;113(3):236-43.
13. Rochat TJ, Richter LM, Doll HA, Buthelezi NP, Tomkins A, Stein A. Depression among pregnant rural South African women undergoing HIV testing. JAMA. 2006;295(12):1376-8.
14. Tuccori M, Testi A, Antonioli L, Formai M, Montagnani S, Ghisu N, et al. Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review. Clin Ther. 2009;31(Pt 1):1426-53.
15. Committee on Drugs, American Academy of Pediatrics. Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn. Pediatrics. 2000;105:880-7.
16. Addis A, Sharabi S, Bonatl M. Risk classification systems for drug use during pregnancy: Are they a reliable source of information? Drug Saf. 2000;23(3):245-53.
17. Bodnar LM, Wisner KL. Nutrition and depression: implications for improving mental health among childbearing-aged women. Biol Psychiatry. 2005;58(9):679-85.
18. Bourre J. Dietary omega-3 fatty acids and psychiatry: mood, behavior, stress, depression, dementia and aging. J Nutr Health Aging. 2005;9(1):31-8.
19. Alpert JE, Mischoulon D, Rubenstein GE, Bottonari K, Nierenberg AA, Fava M. Folinic acid (Leucovorin) as an adjunctive treatment for SSRI- refractory depression. Ann Clin Psychiatry. 2002;14(1):33-8.
20. Parry BL, Sorenson D, Meliska CJ, Basavaraj N, Zirpoli GG, Gamst A, et al. Hormonal Basis of mood and postpartum disorders. Curr Womens Health Rep. 2003;3(3):230-5.
21. Ressler KJ, Nemeroff CB. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety. 2000;12(Suppl 1):2-19.
22. aan het Rot M, Mathew SJ, Charney DS. Neurobiological mechanisms in major depressive disorder. CMAJ. 2009;180(3):305-13.
23. Ruhe HG, Mason NS, Schene AH. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a metaanalysis of monoamine depletion studies. Mol Psychiatry. 2007;12(4):331-59.
24. Williams AL, Cotter A, Sabina A, Girad C, Goodman J, Katz DL. The role for vitamin B-6 as treatment for depression: a systematic review. Fam Pract. 2005;22(5):532-7.
25. Delgado PL. Depression: the case for a monoamine deficiency. J Clin Psychiatry. 2000;61(Supp 6):7-11.
26. Bottiglieri T, Laundy M, Crellin R, Toone BK, Carney MW, Reynolds EH. Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry. 2000;69(2):228-32.
27. Hibbeln JR, Salem N. Dietary polyunsaturated fatty acids and depression: When cholesterol does not satisfy. Am J Clin Nutr. 1995;62(1):1-9.
28. Ramakrishnan U, Imhoff-Kunsch B, DiGirolamo AM. Role of docosahexaenoic acid in maternal and child mental health. Am J Clin Nutr. 2009;89(3):958S-62S.
29. Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Metzler HY. Lowered omega 3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res. 1999;85(3):275-91.
30. Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Mischoulon D, Peet M, et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry. 2006;67(12):1954-67.
31. Peet M, Horrobin DF. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry. 2002;59(10):913-9.
32. Abou-Saleh MT, Ghubash R, Karim L, Krymski M, Bhai I. Hormonal Aspects of Postpartum Depression. Psychoneuroendocrinology. 1998;23(5):465-75.
33. Jolley SN, Elmore S, Barnard KE, Carr DB. Dysregulation of the hypothalamic-pituitaryadrenal axis in postpartum depression. Biol Res Nurs. 2007;8(3):210-22.
34. Harris B, Johns S, Fung H, Thomas R, Walker R, Read G, et al. The hormonal environment of post-natal depression. Br J Psychiatry. 1989;154(5):660-7.
35. Harris B, Lovett L, Smith J, Read G, Walker R, Newcombe R. Cardiff puerperal mood and hormone study. III. Postnatal depression at 5 to 6 weeks postpartum, and its hormonal correlates across the peripartum period. Br J Psychiatry. 1996;168(6):739-44.
36. Okano T, Nomura J. Endocrine study of the maternity blues. Prog Neuropsychopharmacol Biol Psychiatry. 1992;16(6):921-32.
37. Pedersen CA, Johnson JL, Silva S, Bunevicius R, Meltzer-Brody S, Hamer R, et al. Antenatal thyroid correlates of postpartum depression. Psychoneuroendocrinology. 2007;32(3):235-45.
38. Bloch M, Daly RC, Rubinow DR. Endocrine factors in the etiology of postpartum depression. Compr Psychiatry. 2003;44(3):234-46.
39. Miller LJ. Postpartum depression. JAMA. 2002;287(6):762-5.
40. Dennis CL, Janssen PA, Singer J. Identifying women at risk for postpartum depression in the immediate postpartum period. Acta Psychiatr Scand. 2004;110(5):338-46.
41. Allen LH. Vitamin B-12 metabolism and status during pregnancy, lactation and infancy. Adv Exp Med Biol. 1994;352:173-86.
42. The Institute of Medicine [Internet].[cited 2012 Dec 28] Available from: http://www.iom.edu.
43. Al M, van Houwelingen AC, Hornstra G. Long-chain polyunsaturated fatty acids, pregnancy, and pregnancy outcome. Am J Clin Nutr. 2000;71(1 Suppl):285S-91S.
44. Alpert JE, Mischoulon D, Nierenberg AA, Fava M. Nutrition and depression: focus on folate. Nutrition. 2000;16(7-8):544-6.
45. Hibbeln JR, Umhau JC, George DT, Salem N. Do plasma polyunsaturates predict hostility and depression? World Rev Nutr Diet. 1997;82:175-86.
46. Selhub J. Homocysteine Metabolism. Annu Rev Nutr. 1999;19:217-46.
47. Machlin LJ. Handbook of Vitamins: nutritional, biochemical, and clinical aspects (Vol. 13). New York: M. Dekker; 1984.
48. Coppen A, Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. J Affect Disord. 2000;60(2):121-30.
49. Bottiglieri T. Folate, vitamin B12, and neuropsychiatric disorders. Nutr Rev. 2009;54(12):382-90.
50. Ray JG, Laskin CA. Folic acid and homocysteine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systematic review. Placenta. 1999;20(7):519-29.
51. Picciano MF. Pregnancy and lactation: physiological adjustments, nutritional requirements and the role of dietary supplements. J Nutr. 2003;133(6):1997S-2002S.
52. Reynolds EH, Preece JM, Bailey JY, Coppen A. Folate deficiency in depressive illness. Br J Psychiatry. 1970;117(538):287-92.
53. Alpert M, Silva RR, Pouget ER. Prediction of treatment response in geriatric depression from baseline folate level: interaction with an SSRI or a tricyclic antidepressant. J Clin Psychopharmacol. 2003;23(3):309-13.
54. Godfrey PS, Toone BK, Bottliglien T, Laundy M, Reynolds EH, Carney MW, et al. Enhancement of recovery from psychiatric illness by methylfolate. Lancet. 1990;336(8712):392-5.
55. Passeri M, Cucinotta D, Abate G, Senin U, Ventura A, Stramba BM, et al. Oral 5-methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a double- blind multicenter trial. Aging (Milano). 1993;5(1):63-71.
56. Pancherii P, Scapicchio P, DelleChiaie RD. A double-blind, randomized parallel-group, efficacy and safety study of intramuscular S-adenosyl-L-methionine 1,4-butanedisulphonate versus imipramine in patients with major depressive disorder. Int J Neuropsychopharmacol. 2002;5(4):287-94.
57. Papakostas GI, Alpert JE, Fava M. S-adenosyl- methionine in depression: a comprehensive review of the literature. Curr Psychiatry Rep. 2003;5(6):460-6.
58. Spillman M, Fava M. S-adenosyl-methionine in psychiatric disorders: historical perspective and current status. CNS Drugs. 1996;6:416-25.
59. Janicak PG, Lipinski J, Davis JM, Comaty JE, Waternaux C, Cohen B, et al. S-adenosylmethionine in depression: a literature review and preliminary report. Ala J Med Sci. 1988;25:306-13.
60. Caruso I, Fumagalli M, Boccassini L, Puttini P, Giniselli G, Cavallari G. Antidepressant activity of S-adenosylmethionine. Lancet. 1984:1(8382):904.
61. Delle Chiaie R, Pancheri P, Scapicchio P. Efficacy and tolerability of oral and intramuscular S-adenosyl-l-methionine 1,4-butanedisulfonate (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicenter studies. Am J Clin Nutr. 2002;76(5):1172S-6S.
62. Kris-Etherton PM, Taylor DS, Yu-Poth S, Huth P, Moriarty K, Fishell V, et al. Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr. 2000;71(1 Suppl):179S-88S.
63. Klerman GL, Weisman MM. Increasing rates of depression. JAMA. 1989;261(15):2229-35.
64. Sontrop J, Campbell MK. Omega-3 Polyunsaturated fatty acids and depression: a review of the evidence and a methodological critique. Prev Med. 2006;42(1):4-13.
65. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002;21(6):495-505.
66. Edwards R, Peet M, Shay J, Horrobin D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord.1998;48(2-3):149-55.
67. Anderson IM, Parry-Billings M, Newsholme EA. Dieting reduces plasma tryptophan and alters brain 5-HT function in women. Psychol Med. 1990;20(4):785-91.
68. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002;56(8):365-79.
69. De Vriese SR, Christophe AB, Maes M. Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: further evidence that lowered n-PUFAs are related to major depression. Life Sci. 2003;73(25):3181-7.
70. Maes M, Smith R, Christophe A, Cosyns P, Desnyder R, Meltzer H. Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega 6/C20:5 omega 3 ratio in cholesterol esters and phospholipids. J Affect Disord. 1996;38(1):35-46.
71. Hornstra G. Essential fatty acids in mothers and their neonates. Am J Clin Nutr. 2000;71(5 Suppl):1262S-9S.
72. Otto SJ, de Groot R, Hornstra G. Increased risk of postpartum depressive symptoms is associated with slower normalization after pregnancy of the functional docosahexaenoic acid status. Prostaglandins Leukot Essent Fatty Acids. 2003;69(4):237-43.
73. McNamara RK, Carlson SE. Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot Essent Fatty Acids. 2006;75(4):329-49.
74. Hibbeln JR. Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J Affect Disord. 2002;69(1):15-30.
75. Bruinsma KA, Taren DL. Dieting, essential fatty acid intake, and depression. Nutr Rev. 2000;58(4):98-108.
76. Green P, Gispan-Herman I, Yadid G. Increased arachidonic acid concentration in the brain of flinders sensitive line rats: an animal model of depression. J Lipid Res. 2005;46(6):1093-6.
77. Hamazaki T, Sawazaki S, Itomura M, Asaoka E, Nagao Y, Nishimura N, et al. The effect of docosahexaenoic acid on aggression in young adults: a double blind study. J Clin Invest. 1996;97(4):1129-33.
78. Kaplan JR, Manuchk SB, Shively C. The effects of fat and cholesterol on social behavior in monkeys. Psychosom Med. 1991;53(6):634-42.
79. Frances H, Monier C, Bourre JM. Effects of dietary α-linolenic acid deficiency on neuromuscular and cognitive functions in mice. Life Sci. 1995;57(21):1935-47.